Clinical Trial Update: Open-label, Randomized, 2-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Daily PHE Fluctuation of PKU GOLIKE Versus SoC in Patients With PKU. [NA]

View source ↗

Summary

Terminated open-label, randomized 2-way crossover trial assessing daily phenylalanine fluctuation in phenylketonuria patients, comparing PKU GOLIKE to standard …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PKU GOLIKE

Snippet

Sponsor: APR Applied Pharma Research s.a. | Conditions: Phenylketonurias | NA | Status: TERMINATED | Results posted: 2026-03-11